On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Extended deadline (from 1 July to 31 July) 2017 for call to submit papers on effectiveness and cost-effectiveness of screening and prevention of infectious diseases among newly arrived migrants in Europe. Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2013: Volume 18/ Issue 19 Article 1
Back to Table of Contents
Download (pdf)

Eurosurveillance, Volume 18, Issue 19, 09 May 2013
Rapid communications
Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A(H7N9) infections in China, March to April 2013
  1. School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
  2. These authors contributed equally to this work

Citation style for this article: Cowling BJ, Freeman G, Wong JY, Wu P, Liao Q, Lau EH, Wu JT, Fielding R, Leung GM. Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A(H7N9) infections in China, March to April 2013 . Euro Surveill. 2013;18(19):pii=20475. Available online:
Date of submission: 25 April 2013

Between 31 March and 21 April 2013, 102 laboratory-confirmed influenza A(H7N9) infections have been reported in six provinces of China. Using survey data on age-specific rates of exposure to live poultry in China, we estimated that risk of serious illness after infection is 5.1 times higher in persons 65 years and older versus younger ages. Our results suggest that many unidentified mild influenza A(H7N9) infections may have occurred, with a lower bound of 210–550 infections to date.


In recent weeks, increasing numbers of avian influenza A(H7N9) virus infections have been identified in humans in China [1,2]. Laboratory-confirmed cases of influenza A(H7N9) infection have typically suffered serious illness [3,4], and there is a notable excess of confirmed cases in the elderly [3,5]. In the present analysis, we compared the incidence of serious influenza A(H7N9) infections with data on age-specific patterns in exposure to domestic poultry and live poultry markets to estimate the relative seriousness of influenza A(H7N9) and obtain a lower bound on the number of human infections to date.


Poultry exposures in China
We obtained unpublished data on poultry exposures in Shenzhen, a city in Guangdong province on the border with Hong Kong, and in Xiuning, a rural county in Anhui province in eastern China. In each location, a two-stage household-based cluster survey was conducted to assess poultry exposures based on average annual visits to poultry wet markets (Shenzhen, n=2,058), and ownership of backyard poultry (Xiuning, n=2,892). Trained investigators conducted each face-to-face interview with selected households, and every family member who met the inclusion criteria (aged at least five years, and resident in the study area for at least three months) was interviewed. Poultry wet markets were defined as places where small animals and poultry may be purchased alive or slaughtered just before purchase. The surveys were conducted from July to September 2007.

Data on poultry exposures in urban and semi-rural areas of Guangzhou, the capital of Guangdong province in Southern China, were obtained through face-to-face interviews, from January through March 2006 [6]. Households were selected for interview through stratified cluster sampling in the ten urban districts (n=1,363) and two satellite towns (n=187) of Guangzhou. One adult per selected household was interviewed. We assessed household exposures to retail and domestic poultry in both urban and semi-rural locations based on average annual visits to poultry wet markets to purchase live poultry, and ownership of backyard poultry [6].

Avian influenza A(H7N9) cases
Information on laboratory-confirmed human infections with influenza A(H5N1) and A(H7N9) was obtained from official notifications, including age, geographic location, and seriousness of disease (mild/serious). The definition for an influenza A(H7N9) case is given elsewhere [3]. A serious case was defined as a laboratory-confirmed influenza A(H7N9) case that required hospital admission for medical reasons, i.e. with a complication such as pneumonia, rather than merely for isolation. Cases defined as serious included all fatal laboratory-confirmed cases. The age-specific populations of provinces in China were obtained from the 2010 population census of the People's Republic of China [7].

Statistical analysis
We specified a model for the observed number of serious influenza A(H7N9) infections under the assumption that the risk of infection was directly proportional to the risk of exposure, while the seriousness of infection varied by age. Specifically, we modelled Xij, the number of serious influenza A(H7N9) infections in age group i and area j, as following a Poisson distribution with mean Aij×pij×ri, where Aij is the population of persons in age group i (i=1 for 0–14 years, 2 for 15–24 years, 3 for 25–34 years, 4 for 35–44 years, 5 for 45–54 years, 6 for 55–64 years, 7 for ≥65 years) and area j (1 for Anhui-urban, 2 for Beijing-urban, 3 for Henan-rural, 4 for Jiangsu-urban, 5 for Jiangsu-rural, 6 for Shanghai-urban, 7 for Zhejiang-urban, 8 for Zhejiang-rural), pij represents the incidence rate of infection by age and area over the time period covered by our analysis, and ri represents the age-specific risk of serious illness if infected. For urban areas (δj=1) and rural areas (δj=0), we specified pijj×Ui×θj+(1-δj)×Vi×θj, where Ui and Vi represent the age-specific rates of exposure in urban and rural areas, respectively, while θj represents the area-specific risk of infection. In our main analysis, we modelled the risk of serious illness conditional on infection as ri taking value rold for age≥65 years and ryoung for age<65 years. We explored other parameterisations for ri such as ri=r7×exp(β×(i-7)) in sensitivity analyses.

We used a Bayesian inferential framework to fit the model to observed data on Xij, Aij and δj, incorporating Uij, and Vij as parameters with strong prior distributions from the survey data to retain uncertainty (as is standard in Bayesian evidence synthesis [8]), and rold as a parameter with a strong prior based on observed mild and serious influenza A(H7N9) cases. We estimated θj and ryoung using independent uninformative uniform priors on the positive real line for each θj and on the (0,1) interval for ryoung. Models were fitted with the Hamiltonian Monte Carlo sampler NUTS [9] using the Stan modelling language in R version 3.0.0 (R Foundation for Statistical Computing, Vienna, Austria). Convergence of the simulations was assessed using the potential scale reduction statistic [10].

After fitting the models, posterior estimates of the model parameters were used to estimate qij,=Aij×pij as the total number of influenza A(H7N9) infections for each age group i and area j. This estimate can be regarded as a lower bound on the number of influenza A(H7N9) infections because it relies on complete ascertainment of all serious influenza A(H7N9) cases, and complete ascertainment of all influenza A(H7N9) infections in people aged 65 years and older. We also estimated βage=rold/ryoung, the relative risk of serious illness conditional on infection in those aged 65 years and older compared with those  younger than 65 years.


Between 31 March and 21 April 2013, 102 laboratory-confirmed human influenza A(H7N9) cases were officially announced in six provinces of China. The affected areas were the cities and provinces around the city of Shanghai on the eastern coast of mainland China (Figure 1).

Figure 1. Geographical location of officially announced serious cases of influenza A(H7N9) virus infection in mainland China, 31 March–21 April 2013 (n=98)


The age distribution of influenza A(H7N9) cases was very different to the age distribution of the 43 influenza A(H5N1) cases reported between 2003 and 2013 in mainland China (Figure 2). In particular, 56% of the influenza A(H7N9) cases were persons aged 60 years or older, whereas the majority of influenza A(H5N1) cases were young adults aged 20 to 39 years. In the eight affected areas, there were a total of 98 serious influenza A(H7N9) cases in a total population of 206 million persons (Table). The cumulative number of serious influenza A(H7N9) cases increased substantially with age particularly in urban locations (Figure 3).

Figure 2. Age distribution of laboratory-confirmed human infections with avian influenza A(H5N1) in 2003–2013 (n=43) and A(H7N9) notified from 31 March 2013 to 21 April 2013 (n=102), mainland China


Table. Serious influenza A(H7N9) cases reported in six provinces of mainland China, and corresponding population denominators, 31 March–21 April 2013 (n=98)


Figure 3. Comparison of age-specific cumulative incidence of serious illness associated with laboratory-confirmed influenza A(H7N9) virus infection, 31 March–21 April 2013, and age-specific poultry exposures, 2006 and 2007, China


We fitted the model described above to data on the incidence rates of serious influenza A(H7N9) cases in the six provinces, along with poultry exposures in urban and rural locations (Figure 2). In the age group of at least 65 years there were 46 serious and one mild infection, so we used a beta(47,2) distribution for the parameter rold.

Based on the exposure data from Shenzhen and Xiuning to reflect exposures in affected urban and rural areas, we obtained the estimate βage=5.06 (95% credibility interval (CI): 2.99–8.15), corresponding to a 5.06-fold increase in the risk of serious illness for those aged 65 years and older versus those younger than 65 years. The estimated values of pij and the observed values of Aij were then used to estimate that there have been at least 323 (95% CI: 214–475) total influenza A(H7N9) infections in the population, including those reported. When we used the exposure data from Guangzhou to reflect exposures in affected urban and rural areas, we estimated βage=5.95 (95% CI: 3.37–10.00), and an estimated minimum number of 352 (95% CI: 225–541) total influenza A(H7N9) infections in adults (because we did not have exposure data for children in Guangzhou).

In sensitivity analyses, results were similar using alternative simple parameterisations for the effect of age. For example when we used ri=r7×exp(β×(i-7)), we obtained an estimated 1.83-fold (95% CI: 1.56–2.18) increase in the risk of serious illness for every ten-year increase in age, and an estimate of at least 334 (95% CI: 239–461) total influenza A(H7N9) infections in the population. The small sample size did not allow us to examine more complex functional forms for ri. All analyses reported above were based on data available until April 25; we repeated the analyses based on data available until May 6 and the relationship between age and seriousness of disease was essentially the same.


Our results suggest that the seriousness of influenza A(H7N9) infections increases with age. Previous reports also identified increases with older age in the seriousness of seasonal influenza [11] and H1N1pdm09 [12,13], although this may partly be due to the role of secondary bacterial pneumonia, whereas many of the influenza A(H7N9) deaths have been associated with primary viral pneumonia [4]. However, the age distribution of serious human infections with avian influenza A(H5N1) is very different (Figure 1). The patterns of exposure to avian influenza A(H5N1) and A(H7N9) viruses by age may not be identical because of the high degree of pathogenicity of influenza A(H5N1) in poultry compared with the absence of disease in poultry with influenza A(H7N9) infections [4], at least before to the national influenza A(H5N1) vaccination programme in poultry was introduced in 2006–07. Exposures to sick or dead poultry would be more frequent in farms and backyards, compared to live poultry markets. In addition, healthcare seeking behaviours may also have changed over the past 10 years. There are various potential explanations for an increased risk of serious illness for influenza A(H5N1) infections in young adults compared to other ages, and these hypotheses deserve further investigation [14].

We estimated that a minimum of 210–550 influenza A(H7N9) infections have occurred by 21 April 2013, assuming that almost all influenza A(H7N9) infections are serious in the elderly and that all serious infections have been identified. This estimate is therefore a lower bound on the number of total influenza A(H7N9) infections, and for these two reasons the real figure may be substantially higher. There could be some underascertainment of serious influenza A(H7N9) infections through failure to seek care or failure to be tested early enough in the course of disease to permit identification of the influenza infection [5]. Our estimate is also dependent on the assumption that age-specific patterns of exposure to retail and domestic poultry in affected areas of China in 2011 are similar to the patterns measured in Guangzhou, Shenzhen and Xiuning in 2006 and 2007. We are not aware of data on age-specific patterns in poultry exposures from eastern China other than our unpublished data from Xiuning, and future collection of such data from across China (and across South-east Asia) in urban and rural settings would be extremely useful.

Our estimates are limited by the lack of data on exposures in affected urban and rural areas. In particular, the higher risk for infection in males compared to females could be due to variation in sex-specific rates of exposure by region [5]. Without data on such differences, we did not include sex in our models. Most confirmed cases report exposure to live poultry [3] and this remains the most likely source of infection for the majority of influenza A(H7N9) cases. However, the exposure distributions used in our analysis may not fully capture the age-specific risk profile, if there are other sources of infection apart from retail and domestic poultry. As of April 25, we are not aware of provinces in China with laboratory-confirmed A(H7N9) cases in poultry but not in humans. Finally, no published information is available on population levels of immunity to influenza A(H7N9), although preliminary investigations suggest very low antibody levels against influenza A(H7N9) virus in all ages, and we assumed there was no heterogeneity in immunity by age. If older persons had some degree of immunity against influenza A(H7N9) through potential past exposures to avian influenza viruses, this would imply an even higher number of undetected infections in adults based on our method.

In conclusion, we estimated a lower bound for the number of influenza A(H7N9) infections based on the possible age distribution of exposures and varying seriousness of infection by age. More accurate estimates of the risk of influenza A(H7N9) infection and the age-specific seriousness of infection could be provided by detailed seroepidemiological studies in affected areas [15].

We thank Vicky Fang, Angel Li, Michael Ni and Hoi Wa Wong for technical assistance.
This research was supported by the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558), the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region, and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.

Potential conflicts of interest
BJC reports receipt of research funding from MedImmune Inc., and consults for Crucell NV. GML has received speaker honoraria from HSBC and CLSA. The authors report no other potential conflicts of interest.

Authors’ contributions
Designed the study: BJC. Collected, synthesised and analysed data: BJC, GF, JYW, PW, QL, RF. Wrote the first draft: BJC. Interpreted the results and revised the article: GF, JYW, QL, PW, JTW, EHYL, RF, GML. All authors read and approved the final manuscript

  1. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013;Apr 11. [Epub ahead of print].
  2. Uyeki TM, Cox NJ. Global Concerns Regarding Novel Influenza A (H7N9) Virus Infections. N Engl J Med. 2013;Apr 11. [Epub ahead of print].
  3. Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, et al. Preliminary report: epidemiology of the avian influenza A (H7N9) outbreak in China. N Engl J Med. 2013;Apr 24. [Epub ahead of print].
  4. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013;Apr 25. pii: S0140-6736(13)60903-4.
  5. Arima Y, Zu R, Murhekar M, Vong S, Shimadaa T, World Health Organization Regional Office for the Western Pacific Event Management Team. Human infections with avian influenza A(H7N9) virus in China: preliminary assessments of the age and sex distribution. Western Pac Surveill Response J. 2013;4(2). doi:10.5365/wpsar.2013.4.2.005.
  6. Liao Q, Lam WW, Jiang CQ, Ho EY, Liu YM, Zhang WS, et al. Avian influenza risk perception and live poultry purchase in Guangzhou, China, 2006. Risk Anal 2009; 29:416-24.
  7. National Bureau of Statistics of China. Tabulation of the 2010 population census of the People's Republic of China. Beijing: National Bureau of Statistics of China. [Accessed 25 April 2013]. Available from:
  8. Presanis AM, De Angelis D, New York City Swine Flu Investigation Team, Hagy A, Reed C, Riley S, et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med. 2009; 6(12):e1000207.
  9. Hoffman MD, Gelman A. The no-U-turn sampler: adaptively setting path lengths in hamiltonian monte carlo. arXiv:1111.4246v1 [stat.CO]. 18 Nov 2011.
  10. Gelman A, Rubin DB. Inference from iterative simulation using multiple sequence. Statist Sci. 1992;7(4):457-72.
  11. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis. 2000;181(3):831-7. PMid:10720501 
  12. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8(7):e1001053. PMid:21750667 PMCid:3130021
  13. Wong JY, Wu P, Nishiura H, Goldstein E, Lau EH, Yang L, et al. Infection Fatality Risk of the Pandemic A(H1N1)2009 Virus in Hong Kong. Am J Epidemiol. 2013;177(8):834-40.
  14. Liem NT, Tung CV, Hien ND, Hien TT, Chau NQ, Long HT, et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis. 2009;48(12):1639-46.
  15. Van Kerkhove MD, Broberg E, Engelhardt OG, Wood J, Nicoll A, CONSISE steering committee. The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy. Influenza Other Respi Viruses. 2013;7(3):231-4. 


Back to Table of Contents
Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.